QA: Applied Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001697532_2023_Applied_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001697532, Applied Therapeutics Inc.

  xvar xval
0 AssetsCurrent 37,308,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,055,000
4 LiabilitiesCurrent 33,424,000
5 LiabilitiesNoncurrent 878,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 27,316,000
9 ResearchAndDevelopmentExpense 55,634,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 442,000
13 remainder_ComprehensiveNetIncome 158,000
  yvar yval
0 Assets 38,363,000
1 Liabilities 34,302,000
2 Expenses 82,950,000
3 Revenues 0
4 StockholdersEquity 4,061,000
5 NetIncome -82,508,000
6 ComprehensiveNetIncome -82,429,000
7 BaseVar 78,107,500
8 EconomicCapitalRatio -2.08

Edgar->Model Mapping

Feature Distribution

Change over Time